Catabasis Pharma (CATB) Tops Q4 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. CMG
7. TENB
8. BIIB
9. KLAC
10. ETSY

Go back to Catabasis Pharma (CATB) Tops Q4 EPS by 5c

Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Recent Corporate Highlights

March 16, 2017 4:10 PM EDT

-- Part C of MoveDMD® Trial of Edasalonexent in Duchenne Muscular Dystrophy Ongoing --

-- Continued Advancement of Rare Disease Pipeline with CAT-5571, a Potential Treatment for Cystic Fibrosis, and CAT-4001, a Potential Treatment for Neurodegenerative Diseases --

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB), a clinical-stage... More